Año: 2018
Journal Impact Factor (JIF): 1.9350
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 185/230 | Q4 | T3 | D9 |
Año: 2018
Journal Citation Indicator (JCI): 0,500
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 203/302 | Q3 | T3 | D7 | 32,95 |
Año:
2018
CiteScore:
3,200
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 190/323 | Q3 | T2 | D6 |
| Cancer Research | 143/194 | Q3 | T3 | D8 |
SJR año:
2018
Factor de Impacto:
0,722
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 901/2805 | Q2 | T1 | D4 |
| Oncology | 196/401 | Q3 | T2 | D5 |
| Cancer Research | 140/241 | Q3 | T2 | D6 |
| Agencia | Código de Proyecto |
|---|---|
| Cancer Research Funds of Radiumhemmet at Karolinska Institute, Stockholm, Sweden | - |
| Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP) | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Stockholm University; Eduardo Mondlane University (Sweden) | |
| 2 | Ureba, A | Stockholm University (Sweden) |
| 3 | Gubanski, M | Karolinska Institute Department of Oncology-Pathology (Sweden) |
| 4 | Lind, PA | Karolinska Institute Department of Oncology-Pathology; Sodersjukhuset Hospital (Sweden) |
| 5 | Siegbahn, A | Karolinska Institute Department of Oncology-Pathology; Sodersjukhuset Hospital (Sweden) |